Construction of a Cuproptosis-Related lncRNA Prognostic Model for Bladder Urothelial Carcinoma and Screening of Potential Drugs

Figure 4

OS and PFS analyses between high- and low- risk groups in Train group and Test group. (a) OS analysis of all risk lncRNAs with high and low risk. (b) OS analysis of train group with high and low risk. (c) OS analysis of test group with high and low risk. (d) PFS analysis of all risk lncRNAs with high and low risk.

(a)

(b)

(c)

(d)